Publications by authors named "Deanna Mitchell"

Claim this Profile
M
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Giselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, Jacqueline Kraveka, William Ferguson, Deanna Mitchell

Genome Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Javier Oesterheld, William Ferguson, Jacqueline M Kraveka, Genevieve Bergendahl, Thomas Clinch, Deanna S Mitchell

J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
Don Eslin, Peter E Zage, Genevieve Bergendahl, Elizabeth Lewis, William Roberts, Deanna Mitchell

Int J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
Jacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, William Ferguson, Javier Oesterheld, Deanna Mitchell

Cancer Rep (Hoboken)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.
Sara A Byron, William P D Hendricks, Abhinav B Nagulapally, Jacqueline M Kraveka, William S Ferguson, Deanna Mitchell

Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.
Elizabeth C Lewis, Jacqueline M Kraveka, William Ferguson, Don Eslin, Valerie I Brown, Deanna Mitchell

Int J Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance DFMO Increases Survival in High Risk Neuroblastoma.
Giselle L Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P Bond, Kathleen Neville, Deanna Mitchell

Sci Rep· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
Giselle L Saulnier Sholler, Eugene W Gerner, Genevieve Bergendahl, Robert B MacArthur, Alyssa VanderWerff, Deanna Mitchell

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma.
Deanna Mitchell, Genevieve Bergendahl, William Ferguson, William Roberts, Timothy Higgins

Pediatr Blood Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.
Giselle L Saulnier Sholler, Jeffrey P Bond, Genevieve Bergendahl, Akshita Dutta, Julie Dragon, Deanna Mitchell

Cancer Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance.
David J Monsma, David M Cherba, Patrick J Richardson, Sean Vance, Sanjeet Rangarajan, Deanna Mitchell

Pediatr Blood Cancer· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response.
Dominic W Pelle, Jonathan W Ringler, Jacqueline D Peacock, Kevin Kampfschulte, Donald J Scholten, Deanna S Mitchell

Transl Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-induced osteosarcoma of the hand: case report.
Mark E Puhaindran, Kendall Hamilton, Stacy Schlumbohm, Maria Rich, Deanna Mitchell

J Hand Surg Am· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood management in pediatric spinal deformity surgery: review of a 2-year experience.
Nabil Hassan, Matthew Halanski, Jeni Wincek, Diann Reischman, Dominic Sanfilippo, Deanna Mitchell

Transfusion· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal nodular hyperplasia in oncology patients.
Joseph Junewick, Deanna Mitchell

Pediatr Radiol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary thoracoscopic gross total resection of neuroblastoma.
James M DeCou, Marc G Schlatter, Deanna S Mitchell, Randel S Abrams

J Laparoendosc Adv Surg Tech A· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mechanism for substrate-Induced formation of 6-hydroxyflavin mononucleotide catalyzed by C30A trimethylamine dehydrogenase.
Xingliang Lu, Dejan Nikolic, Deanna J Mitchell, Richard B van Breemen, John A Mersfelder

Bioorg Med Chem Lett· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis